
Envista Holdings Corporation NVST
$ 25.51
-1.22%
Annual report 2025
added 02-12-2026
Envista Holdings Corporation DPO Ratio 2011-2026 | NVST
Annual DPO Ratio Envista Holdings Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.2 | 56.8 | 66.1 | 69.1 | 71 | 92.5 | 61.3 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 92.5 | 54.2 | 67.3 |
Quarterly DPO Ratio Envista Holdings Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49 | 54.9 | - | 55.4 | 51.7 | 60.5 | - | 58.8 | 58.5 | 71.6 | - | 32.5 | 29.9 | 65 | - | 69.2 | 57.5 | 73.1 | - | 83.6 | 101 | 75.2 | - | 64.9 | 59.6 | 65.4 | - | 33.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 101 | 29.9 | 60.5 |
DPO Ratio of other stocks in the Medical instruments industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Baxter International
BAX
|
45.6 | $ 16.47 | -1.08 % | $ 8.45 B | ||
|
Atrion Corporation
ATRI
|
31.9 | - | - | $ 810 M | ||
|
Luminex Corporation
LMNX
|
45.3 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
218 | - | -9.52 % | $ 20.6 M | ||
|
Alcon
ALC
|
63.6 | $ 74.46 | -0.25 % | $ 40.4 B | ||
|
The Cooper Companies
COO
|
72.6 | $ 69.5 | -1.13 % | $ 13.8 B | ||
|
Antares Pharma, Inc.
ATRS
|
93.7 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
26.4 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
3.31 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
61.4 | - | -0.05 % | $ 10.3 B | ||
|
Varian Medical Systems, Inc.
VAR
|
39.5 | - | -0.02 % | $ 16.3 B | ||
|
electroCore
ECOR
|
195 | $ 7.04 | - | $ 59.7 K | ||
|
Ekso Bionics Holdings
EKSO
|
91.4 | $ 9.6 | -1.54 % | $ 23.3 M | ||
|
BioLife Solutions
BLFS
|
130 | $ 19.0 | -1.4 % | $ 875 M | ||
|
AtriCure
ATRC
|
68.7 | $ 28.76 | -1.47 % | $ 1.37 B | ||
|
Glaukos Corporation
GKOS
|
67.2 | $ 115.08 | -1.41 % | $ 5.57 B | ||
|
Haemonetics Corporation
HAE
|
41.9 | $ 58.1 | -0.54 % | $ 2.92 B | ||
|
Harvard Bioscience
HBIO
|
42 | $ 5.53 | - | $ 245 M | ||
|
iRhythm Technologies
IRTC
|
7.87 | $ 115.36 | -1.59 % | $ 3.69 B | ||
|
Repro Med Systems
KRMD
|
46.1 | $ 4.25 | -0.23 % | $ 196 M | ||
|
Masimo Corporation
MASI
|
84.4 | $ 178.34 | -0.08 % | $ 9.51 B | ||
|
Microbot Medical
MBOT
|
52.9 | $ 2.32 | -1.91 % | $ 106 M | ||
|
Milestone Scientific
MLSS
|
36.5 | $ 0.29 | - | $ 23.8 M | ||
|
Pro-Dex
PDEX
|
35.4 | $ 48.53 | - | $ 160 M | ||
|
ICU Medical
ICUI
|
39.2 | $ 121.67 | -1.08 % | $ 3 B | ||
|
ResMed
RMD
|
34.9 | $ 224.04 | -0.34 % | $ 32.7 B | ||
|
InfuSystem Holdings
INFU
|
62.5 | $ 9.43 | - | $ 195 M | ||
|
Retractable Technologies
RVP
|
46 | $ 0.71 | -0.07 % | $ 21.3 M | ||
|
Isoray
ISR
|
58.4 | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
23.9 | $ 449.17 | -0.75 % | $ 160 B | ||
|
STAAR Surgical Company
STAA
|
74.3 | $ 21.44 | 2.29 % | $ 1.06 B | ||
|
Stereotaxis
STXS
|
124 | $ 1.85 | -1.86 % | $ 168 M | ||
|
LeMaitre Vascular
LMAT
|
13.9 | $ 109.83 | 0.61 % | $ 2.49 B | ||
|
Teleflex Incorporated
TFX
|
47.7 | $ 114.86 | -0.2 % | $ 5.13 B | ||
|
Merit Medical Systems
MMSI
|
30.3 | $ 66.72 | -1.61 % | $ 3.95 B | ||
|
Utah Medical Products
UTMD
|
17.8 | $ 63.75 | 1.3 % | $ 207 M | ||
|
Predictive Oncology
POAI
|
7.25 K | - | - | $ 31.1 M | ||
|
Pulse Biosciences
PLSE
|
1.51 K | $ 21.68 | -5.49 % | $ 1.46 B | ||
|
West Pharmaceutical Services
WST
|
45.7 | $ 258.0 | 0.4 % | $ 18.7 B | ||
|
DENTSPLY SIRONA
XRAY
|
53.7 | $ 11.45 | -1.63 % | $ 2.28 B | ||
|
NeuroMetrix
NURO
|
78.1 | - | 5.05 % | $ 9.02 M | ||
|
STERIS plc
STE
|
31.8 | $ 219.18 | -0.37 % | $ 21.6 B | ||
|
AngioDynamics
ANGO
|
96.2 | $ 9.51 | -3.35 % | $ 389 M | ||
|
Becton, Dickinson and Company
BDX
|
59.3 | $ 154.32 | -0.59 % | $ 44.4 B | ||
|
Nephros
NEPH
|
50.5 | $ 2.81 | -1.75 % | $ 29.2 M | ||
|
OraSure Technologies
OSUR
|
40.1 | $ 3.05 | -1.14 % | $ 224 M | ||
|
Repligen Corporation
RGEN
|
24.3 | $ 116.46 | -0.42 % | $ 6.49 M |